
To own Blue Bird, you need to believe the bus maker can keep turning its mix of alternative powertrains, parts and specialty chassis into durable cash generation without stretching its balance sheet. The new US$600 million credit facility does not by itself change demand drivers such as school fleet renewal, funding for clean buses or tariff and policy noise.
The more practical near term catalyst is execution on capacity expansion and EV and propane unit delivery, supported by accessible liquidity for capex and working capital. The biggest risk still sits on the demand side. Public funding cycles, demographic trends and any pullback in customer ordering could weigh on revenue even with more credit available.
The closing of the expanded senior secured credit facilities on 30 September 2026 ties directly into those operational swing factors. Blue Bird now has a US$300 million revolver and a US$300 million delayed draw term loan with lower SOFR based margins, plus roughly US$670 million of total liquidity reported at closing, which gives management room to fund plants, automation and product programs.
That flexibility comes with responsibilities investors should watch closely. The higher permitted net leverage ceiling of 3.25x, along with an accordion that can flex higher subject to tests, increases the potential debt load if growth or acquisitions are pursued too aggressively. The thesis now leans more on disciplined capital allocation, clean cash conversion and steady demand for cleaner school buses and specialty vehicles.
Blue Bird's analyst case leans heavily on what happens between today and 2029, not just on the fresh US$600 million credit facility. Consensus models tie the story to higher future revenue, slimmer margins and a smaller earnings base than today, which sets a different tone from the balance sheet expansion that management just locked in.
On the top line, forecasters are plugging in 15.5% yearly revenue growth over the next 3 years. That pace underpins a 2029 revenue marker of about US$2.5b in the valuation work, which sits alongside the cleaner liquidity profile that the new lending package has created. The credit headroom can help fund the capacity and product programs that analysts are already baking into these revenue figures, rather than forcing management to rely only on operating cash to support that build out.
Earnings tell a more cautious story. Consensus expects profit to move from US$281.8 million today to US$233.7 million by 2029, which is a decline of about US$48 million. That shift also lines up with a modeled margin move from 17.5% to 9.4% over roughly the same window, so the analyst view builds in a narrower profit pool even as revenue assumptions rise, and that combination will matter for how investors interpret any future draw on the new debt lines.
Valuation work around Blue Bird then layers a higher P/E multiple on those smaller projected earnings. The reports reference a 2029 earnings figure of US$233.7 million and apply a 15.4x P/E to back out a fair value estimate, compared with about 6.4x on earnings today. That leaves readers with a setup where the stock screens as priced below analyst targets even though the consensus earnings line is expected to soften, and the enlarged credit facility simply adds another input to test against those views.
Blue Bird's narrative projects US$2.5b revenue and US$233.7 million earnings by 2029. This requires 15.5% yearly revenue growth and an earnings decrease of about US$48 million from US$281.8 million today.
Uncover why Blue Bird's fair value indicates a 55% potential upside to its current price that may not last much longer.
Some of the most optimistic analysts focus on Blue Bird’s expanded addressable market rather than demand risk. Before this new US$600 million facility, the bullish camp was modeling roughly US$2.6b in 2029 revenue and US$246.0 million in earnings. You can treat those richer forecasts as one possible path that may shift as this funding news gets absorbed.
Explore 4 other Blue Bird fair value estimates, including one that suggests as much as 227% above the current price!
Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.
If the Blue Bird story has sharpened your thinking on balance sheets, earnings power and funding flexibility, it can be useful to compare it with other companies that share similar financial traits. The Simply Wall St Screener lets you filter for specific qualities and quickly build a wider watchlist that fits your own risk and return preferences.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com